Clinical and pharmacological group: & nbsp

NSAIDs - Salicylic acid derivatives

Included in the formulation
АТХ:

M.02.A.X   Other drugs for external use in pain syndrome with diseases of the musculoskeletal system

Pharmacodynamics:

Combined product for external use.

Aminophylline

Inhibits phosphodiesterase, stabilizes cAMP. Suppresses the secretion of histamine in mast cells, blocks adenosine receptors. Has spasmolytic effect.

Diphenhydramine

Blocks H1-gistaminovye receptors, has anti-allergic, m-cholinoblocking action. Inhibits phosphodiesterase, which increases the amount of cAMP. It inhibits the release of mediators of inflammation and allergic reactions.

Indomethacin

Non-selectively suppresses COX1 and COX2, regulating the synthesis of prostaglandins. Has analgesic, antipyretic and anti-inflammatory effect.

Reduces thrombosis, aggregation and adhesion of platelets, suppressing the synthesis of thromboxane A2 in thrombocytes.

Pharmacokinetics:

The drug for topical application, systemic action on the body does not.

Indications:

It is used for the treatment of rheumatic lesions of soft tissues: periarthritis, bursitis, tendovaginitis, fibrositis. Used for osteochondrosis, rheumatic arthrosis, radiculopathy.

XIII.M05-M14.M06.9   Rheumatoid arthritis, unspecified

XIII.M15-M19.M19.9   Osteoarthritis, unspecified

XIII.M20-M25.M24.2   Lesion of ligaments

XIII.M40-M43.M42   Osteocondritis of the spine

XIII.M50-M54.M54.1   Radiculopathy

XIII.M65-M68.M67.9   Lesion of synovium and tendon, unspecified

Contraindications:

Individual intolerance, children up to 3 years.

Carefully:

Pregnancy and lactation, hypersensitivity.

Pregnancy and lactation:

Recommendations for FDA - Category B. Applicable with caution, in cases where the expected effect exceeds the risk to the fetus and newborn.

Dosing and Administration:

Outer, 4-5 cm gel 3-4 times a day for not more than 10 days.

The highest daily dose: 20 cm.

The highest single dose: 5 cm.

Side effects:

Local allergic reactions (itching, burning, hyperemia).

Overdose:

Cases of overdose are not described.

Treatment is symptomatic.

Interaction:

Clinically significant interactions are not described.

Special instructions:

Do not apply to open wounds, mucous membranes, into the oral cavity.

Instructions
Up